Your care team can provide nutrition guidance during your protocol
Retatrutide Phase 3 Results: Trials, Safety, and NHS Outlook Retatrutide phase 3 results are among the most anticipated developments in obesity medicine, as this investigational triple receptor agonist from Eli Lilly moves through its TRIUMPH trial programme
In certain therapy settings, micro-doses of ketamine can help patients approach traumas that their conscious minds have walled off to keep them safe
By exploring combination therapies, individuals can find a comprehensive approach that suits their lifestyle and goals, increasing the likelihood of achieving long-term weight management success
The majority of these discontinuations were due to gastrointestinal-related adverse events, primarily occurring during the rapid dose-escalation phase
Because your gut runs the entire show